Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Benowitz AB"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Brennan PJ; Department of Chemistry, Chemistry Research Laboratory, University of Oxford; Oxford, UK.; Department of Chemistry & Biochemistry, University of California, Los Angeles; Los Angeles, USA., Saunders RE; GSK, Medicines Research Centre; Stevenage, UK., Spanou M; PerkinElmer; Beaconsfield, UK., Serafini M; Department of Chemistry, Chemistry Research Laboratory, University of Oxford; Oxford, UK., Sun L; Chemical Biology Program, Memorial Sloan Kettering Cancer Center; New York, USA., Heger GP; GSK, Medicines Research Centre; Stevenage, UK., Konopacka A; GSK, Medicines Research Centre; Stevenage, UK., Beveridge RD; Virus Screening Facility, Weatherall Institute of Molecular Medicine, University of Oxford; Oxford, UK., Gordon L; GSK, Medicines Research Centre; Stevenage, UK., Bunally SB; GSK, Medicines Research Centre; Stevenage, UK., Saudemont A; GSK, Medicines Research Centre; Stevenage, UK., Benowitz AB; GSK, Medicines Research Centre; Stevenage, UK., Martinez-Fleites C; GSK, Medicines Research Centre; Stevenage, UK., Queisser MA; GSK, Medicines Research Centre; Stevenage, UK., An H; Chemical Biology Program, Memorial Sloan Kettering Cancer Center; New York, USA., Deane CM; Department of Statistics, University of Oxford; Oxford, UK., Hann MM; GSK, Medicines Research Centre; Stevenage, UK., Brayshaw LL; GSK, Medicines Research Centre; Stevenage, UK., Conway SJ; Department of Chemistry, Chemistry Research Laboratory, University of Oxford; Oxford, UK.; Department of Chemistry & Biochemistry, University of California, Los Angeles; Los Angeles, USA.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2024 Mar 16. Date of Electronic Publication: 2024 Mar 16.
Autor:
Benowitz AB; Medicine Design, GlaxoSmithKline, Gunnels Wood Road, Stevenage, SG1 2NY, UK., Scott-Stevens PT; In Vitro/In Vivo Translation, GlaxoSmithKline, Gunnels Wood Road, Stevenage, SG1 2NY, UK., Harling JD; Medicine Design, GlaxoSmithKline, Gunnels Wood Road, Stevenage, SG1 2NY, UK.
Publikováno v:
Future medicinal chemistry [Future Med Chem] 2022 Jan; Vol. 14 (3), pp. 119-121. Date of Electronic Publication: 2021 Sep 16.
Autor:
Law RP; GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK., Nunes J; GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK., Chung CW; GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK., Bantscheff M; Cellzome GmbH, a GSK company, Meyerhofstraße 1, 69117, Heidelberg, Germany., Buda K; GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK., Dai H; GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK., Evans JP; GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK., Flinders A; GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK., Klimaszewska D; GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK., Lewis AJ; GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK., Muelbaier M; Cellzome GmbH, a GSK company, Meyerhofstraße 1, 69117, Heidelberg, Germany., Scott-Stevens P; GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK., Stacey P; GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK., Tame CJ; GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK., Watt GF; GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK., Zinn N; Cellzome GmbH, a GSK company, Meyerhofstraße 1, 69117, Heidelberg, Germany., Queisser MA; GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK., Harling JD; GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK., Benowitz AB; GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK.
Publikováno v:
Angewandte Chemie (International ed. in English) [Angew Chem Int Ed Engl] 2021 Oct 18; Vol. 60 (43), pp. 23327-23334. Date of Electronic Publication: 2021 Sep 17.
Autor:
Pappalardi MB; Cancer Epigenetics Research Unit, Oncology, GlaxoSmithKline, Collegeville, PA, USA., Keenan K; Cancer Epigenetics Research Unit, Oncology, GlaxoSmithKline, Collegeville, PA, USA., Cockerill M; Drug Discovery Unit, Cancer Research UK Manchester Institute, University of Manchester, Alderley Park, Macclesfield, UK.; These authors contributed equally: Mark Cockerill, Wendy A. Kellner., Kellner WA; Cancer Epigenetics Research Unit, Oncology, GlaxoSmithKline, Collegeville, PA, USA.; These authors contributed equally: Mark Cockerill, Wendy A. Kellner., Stowell A; Drug Discovery Unit, Cancer Research UK Manchester Institute, University of Manchester, Alderley Park, Macclesfield, UK., Sherk C; Cancer Epigenetics Research Unit, Oncology, GlaxoSmithKline, Collegeville, PA, USA., Wong K; Cancer Epigenetics Research Unit, Oncology, GlaxoSmithKline, Collegeville, PA, USA., Pathuri S; Department of Epigenetics and Molecular Carcinogenesis, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Briand J; Medicinal Science & Technology, GlaxoSmithKline, Collegeville, PA, USA., Steidel M; Cellzome GmbH, Functional Genomics, GlaxoSmithKline, Heidelberg, Germany., Chapman P; Drug Discovery Unit, Cancer Research UK Manchester Institute, University of Manchester, Alderley Park, Macclesfield, UK., Groy A; Future Pipeline Discovery, GlaxoSmithKline, Collegeville, PA, USA., Wiseman AK; Center for Epigenetics, Van Andel Research Institute, Grand Rapids, MI, USA., McHugh CF; Cancer Epigenetics Research Unit, Oncology, GlaxoSmithKline, Collegeville, PA, USA., Campobasso N; Medicinal Science & Technology, GlaxoSmithKline, Collegeville, PA, USA., Graves AP; Medicinal Science & Technology, GlaxoSmithKline, Collegeville, PA, USA., Fairweather E; Drug Discovery Unit, Cancer Research UK Manchester Institute, University of Manchester, Alderley Park, Macclesfield, UK., Werner T; Cellzome GmbH, Functional Genomics, GlaxoSmithKline, Heidelberg, Germany., Raoof A; Drug Discovery Unit, Cancer Research UK Manchester Institute, University of Manchester, Alderley Park, Macclesfield, UK., Butlin RJ; Drug Discovery Unit, Cancer Research UK Manchester Institute, University of Manchester, Alderley Park, Macclesfield, UK., Rueda L; Cancer Epigenetics Research Unit, Oncology, GlaxoSmithKline, Collegeville, PA, USA., Horton JR; Department of Epigenetics and Molecular Carcinogenesis, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Fosbenner DT; Cancer Epigenetics Research Unit, Oncology, GlaxoSmithKline, Collegeville, PA, USA., Zhang C; Cancer Epigenetics Research Unit, Oncology, GlaxoSmithKline, Collegeville, PA, USA., Handler JL; Cancer Epigenetics Research Unit, Oncology, GlaxoSmithKline, Collegeville, PA, USA., Muliaditan M; Drug Metabolism and Pharmacokinetics Modelling, GlaxoSmithKline, Stevenage, UK., Mebrahtu M; Medicinal Science & Technology, GlaxoSmithKline, Collegeville, PA, USA., Jaworski JP; Medicinal Science & Technology, GlaxoSmithKline, Collegeville, PA, USA., McNulty DE; Medicinal Science & Technology, GlaxoSmithKline, Collegeville, PA, USA., Burt C; Drug Discovery Unit, Cancer Research UK Manchester Institute, University of Manchester, Alderley Park, Macclesfield, UK., Eberl HC; Cellzome GmbH, Functional Genomics, GlaxoSmithKline, Heidelberg, Germany., Taylor AN; Medicinal Science & Technology, GlaxoSmithKline, Collegeville, PA, USA., Ho T; Medicinal Science & Technology, GlaxoSmithKline, Collegeville, PA, USA., Merrihew S; Cancer Epigenetics Research Unit, Oncology, GlaxoSmithKline, Collegeville, PA, USA., Foley SW; Cancer Epigenetics Research Unit, Oncology, GlaxoSmithKline, Collegeville, PA, USA., Rutkowska A; Cellzome GmbH, Functional Genomics, GlaxoSmithKline, Heidelberg, Germany., Li M; Cancer Epigenetics Research Unit, Oncology, GlaxoSmithKline, Collegeville, PA, USA., Romeril SP; Cancer Epigenetics Research Unit, Oncology, GlaxoSmithKline, Collegeville, PA, USA., Goldberg K; Drug Discovery Unit, Cancer Research UK Manchester Institute, University of Manchester, Alderley Park, Macclesfield, UK., Zhang X; Department of Epigenetics and Molecular Carcinogenesis, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kershaw CS; Drug Discovery Unit, Cancer Research UK Manchester Institute, University of Manchester, Alderley Park, Macclesfield, UK., Bantscheff M; Cellzome GmbH, Functional Genomics, GlaxoSmithKline, Heidelberg, Germany., Jurewicz AJ; Medicinal Science & Technology, GlaxoSmithKline, Collegeville, PA, USA., Minthorn E; Cancer Epigenetics Research Unit, Oncology, GlaxoSmithKline, Collegeville, PA, USA., Grandi P; Cellzome GmbH, Functional Genomics, GlaxoSmithKline, Heidelberg, Germany., Patel M; Medicinal Science & Technology, GlaxoSmithKline, Collegeville, PA, USA., Benowitz AB; Future Pipeline Discovery, GlaxoSmithKline, Collegeville, PA, USA., Mohammad HP; Cancer Epigenetics Research Unit, Oncology, GlaxoSmithKline, Collegeville, PA, USA., Gilmartin AG; Future Pipeline Discovery, GlaxoSmithKline, Collegeville, PA, USA., Prinjha RK; Cancer Epigenetics Research Unit, Oncology, GlaxoSmithKline, Collegeville, PA, USA., Ogilvie D; Drug Discovery Unit, Cancer Research UK Manchester Institute, University of Manchester, Alderley Park, Macclesfield, UK., Carpenter C; Cancer Epigenetics Research Unit, Oncology, GlaxoSmithKline, Collegeville, PA, USA., Heerding D; Cancer Epigenetics Research Unit, Oncology, GlaxoSmithKline, Collegeville, PA, USA., Baylin SB; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA., Jones PA; Center for Epigenetics, Van Andel Research Institute, Grand Rapids, MI, USA., Cheng X; Department of Epigenetics and Molecular Carcinogenesis, University of Texas MD Anderson Cancer Center, Houston, TX, USA., King BW; Cancer Epigenetics Research Unit, Oncology, GlaxoSmithKline, Collegeville, PA, USA., Luengo JI; Cancer Epigenetics Research Unit, Oncology, GlaxoSmithKline, Collegeville, PA, USA., Jordan AM; Drug Discovery Unit, Cancer Research UK Manchester Institute, University of Manchester, Alderley Park, Macclesfield, UK., Waddell I; Drug Discovery Unit, Cancer Research UK Manchester Institute, University of Manchester, Alderley Park, Macclesfield, UK., Kruger RG; Cancer Epigenetics Research Unit, Oncology, GlaxoSmithKline, Collegeville, PA, USA., McCabe MT; Cancer Epigenetics Research Unit, Oncology, GlaxoSmithKline, Collegeville, PA, USA.
Publikováno v:
Nature cancer [Nat Cancer] 2021 Oct; Vol. 2 (10), pp. 1002-1017. Date of Electronic Publication: 2021 Sep 27.
Autor:
Schneider M; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, UK.; Open Targets, Wellcome Genome Campus, Hinxton, UK., Radoux CJ; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, UK.; Open Targets, Wellcome Genome Campus, Hinxton, UK.; Exscientia, Oxford, UK., Hercules A; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, UK.; Open Targets, Wellcome Genome Campus, Hinxton, UK., Ochoa D; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, UK.; Open Targets, Wellcome Genome Campus, Hinxton, UK., Dunham I; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, UK.; Open Targets, Wellcome Genome Campus, Hinxton, UK., Zalmas LP; Open Targets, Wellcome Genome Campus, Hinxton, UK.; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Hessler G; Integrated Drug Discovery, Sanofi-Aventis Deutschland, Frankfurt am Main, Germany., Ruf S; Integrated Drug Discovery, Sanofi-Aventis Deutschland, Frankfurt am Main, Germany., Shanmugasundaram V; Bristol Myers Squibb, Cambridge, MA, USA., Hann MM; GlaxoSmithKline, GSK Medicines Research Centre, Stevenage, UK., Thomas PJ; GlaxoSmithKline, GSK Medicines Research Centre, Stevenage, UK., Queisser MA; GlaxoSmithKline, GSK Medicines Research Centre, Stevenage, UK., Benowitz AB; GlaxoSmithKline, GSK Medicines Research Centre, Stevenage, UK., Brown K; GlaxoSmithKline, Collegeville, PA, USA.; Agenus, Lexington, MA, USA., Leach AR; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, UK. arl@ebi.ac.uk.; Open Targets, Wellcome Genome Campus, Hinxton, UK. arl@ebi.ac.uk.
Publikováno v:
Nature reviews. Drug discovery [Nat Rev Drug Discov] 2021 Oct; Vol. 20 (10), pp. 789-797. Date of Electronic Publication: 2021 Jul 20.
Autor:
Stacey P; Medicine Design, GlaxoSmithKline, Stevenage, UK., Lithgow H; Medicine Design, GlaxoSmithKline, Stevenage, UK.; Department of Pure and Applied Chemistry, WestCHEM, University of Strathclyde, Glasgow, UK., Lewell X; Medicine Design, GlaxoSmithKline, Stevenage, UK., Konopacka A; Medicine Design, GlaxoSmithKline, Stevenage, UK., Besley S; Medicine Design, GlaxoSmithKline, Stevenage, UK., Green G; Medicine Design, GlaxoSmithKline, Stevenage, UK., Whatling R; Medicine Design, GlaxoSmithKline, Stevenage, UK., Law R; Medicine Design, GlaxoSmithKline, Stevenage, UK., Röth S; MRC Protein Phosphorylation and Ubiquitylation Unit (PPU), University of Dundee, Dundee, UK., Sapkota GP; MRC Protein Phosphorylation and Ubiquitylation Unit (PPU), University of Dundee, Dundee, UK., Smith IED; Medicine Design, GlaxoSmithKline, Stevenage, UK., Burley GA; Department of Pure and Applied Chemistry, WestCHEM, University of Strathclyde, Glasgow, UK., Harling J; Medicine Design, GlaxoSmithKline, Stevenage, UK., Benowitz AB; Medicine Design, GlaxoSmithKline, Stevenage, UK., Queisser MA; Medicine Design, GlaxoSmithKline, Stevenage, UK., Muelbaier M; Cellzome GmbH, a GSK company, Heidelberg, Germany.
Publikováno v:
SLAS discovery : advancing life sciences R & D [SLAS Discov] 2021 Aug; Vol. 26 (7), pp. 885-895. Date of Electronic Publication: 2021 May 27.